USP22 and melanoma: To identify potential USP22‐targeting molecules with clinical relevance, we conducted a screening of 173 antitumor drugs obtained from the US FDA‐approved drug library using western blotting assay in SK‐Mel‐28 melanoma cells (Figures 6A and S5).35